Biotechnology in Asia-Pacific

Nov 25, 2016 - MarketLine - 35 pages - USD $350
Report Summary Table of Contents Companies Request Details Related
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Report Synopsis
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
  • Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
Reasons To Buy
  • What was the size of the Asia-Pacific biotechnology market by value in 2016?
  • What will be the size of the Asia-Pacific biotechnology market in 2021?
  • What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Asia-Pacific's biotechnology market?
Key Report Highlights
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The Asia-Pacific biotechnology market is expected to generate total revenues of $86.8bn in 2016, representing a compound annual growth rate (CAGR) of 6% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $47.2bn, equivalent to 54.4% of the market's overall value.

Japan continues to be the most valuable biotechnology in the Asia-Pacific region, leading to investment which will continue the strong recent performances of the industry. Biotechnology in Japan is unusually balanced; most countries biotech industry is heavily weighted in favor of medicine and healthcare.

Order Today!
FORMAT: PDF $350 USD
LICENSE: Single User
DELIVERY: By Email - 1 Business Day


The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to the highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away


BEST PRICE GUARANTEE
We are committed to providing the best research at the lowest cost. We will match any published price for the same report, guaranteed!

EASY ORDERING
Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

About the Publisher
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. MarketLine is wholly owned subsidiary of Datamonitor.